Prostate Health Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067245
  • December 2021
  • Pharmaceuticals
  • 125 Pages
Report Description

This report is a comprehensive study that examines the Prostate Health industry in depth. With reference to key regions and major nations, the study specifies the product type of Prostate Health as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Prostate Health market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Prostate Health market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Prostate Health market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Prostate Health Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Prostate Health market study. The market dynamics and factors such as the threat of a Prostate Health substitute, the threat of new entrants into the Prostate Health market, buyer bargaining power, supplier bargaining power to Prostate Health providing companies, and internal rivalry among Prostate Health providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Prostate Health market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Prostate Health industry.
 
Prostate Health Market Key Trends Analysis

The important factors influencing the growth of the Prostate Health market have been examined in this report. The driving factors that are boosting demand for Prostate Healths and the restraining factors that are slowing growth of the Prostate Health industry are addressed in depth, as well as their implications for the worldwide Prostate Health market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Prostate Health Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Prostate Health industry. On the basis of current and future trends, all segments of the Prostate Health industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Prostate Health Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Prostate Health market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Prostate Health market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Prostate Health market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Prostate Health market. All important stakeholders in the Prostate Health value chain and technological ecosystem are expected to benefit from the insights offered in the Prostate Health market research study.

In order to provide a broader understanding of the top competitors in the Prostate Health market, the research includes a company market share analysis. Eli Lilly and Company (US), Pfizer Inc. (US), Merck & Co. Inc. (US), GlaxoSmithKline plc. (UK), Abbott (US), Astellas Pharma Inc. (Japan) are among the major participants in the global Prostate Health industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Eli Lilly and Company (US), Pfizer Inc. (US), Merck & Co. Inc. (US), GlaxoSmithKline plc. (UK), Abbott (US), Astellas Pharma Inc. (Japan)
 
Major Highlights of the Prostate Health Market report study:
  • An in-depth examination of the global Prostate Health industry will be published soon.
  • The study examines the global Prostate Health market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Prostate Health industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Prostate Health market is being shaped by several major trends.
  • The size of the Prostate Health market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Prostate Health market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Prostate Health market as follows:
Global Prostate Health Market: By Product Type

  • Prostate Cancer
  • Benign Prostate Hyperplasia
  • 5 Alpha Reductase
  • Prostatitis

Global Prostate Health Market: By Application
  • Application I
  • Application II
  • Application III

Global Prostate Health Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Prostate Health market.
  • Universities and students
  • Other companies in the Prostate Health market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Prostate Health market

Manufacturers and Segments

  • Eli Lilly and Company (US)
  • Pfizer Inc. (US)
  • Merck & Co. Inc. (US)
  • GlaxoSmithKline plc. (UK)
  • Abbott (US)
  • Astellas Pharma Inc. (Japan)
  • Prostate Cancer
  • Benign Prostate Hyperplasia
  • 5 Alpha Reductase
  • Prostatitis
  • Application I
  • Application II
  • Application III

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Prostate Health Market Snapshot
          2.1.1. Global Prostate Health Market By Prostate Cancer,2019
               2.1.1.1.
               2.1.1.2.Prostate Cancer
               2.1.1.3.Benign Prostate Hyperplasia
               2.1.1.4.5 Alpha Reductase
          2.1.2. Global Prostate Health Market By Application I,2019
               2.1.2.1.
               2.1.2.2.Application I I
               2.1.2.3.Application I II
          2.1.3. Global Prostate Health Market By End-use,2019
          2.1.4. Global Prostate Health Market By Geography,2019

3. Global Prostate Health Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Prostate Health Market Size (US$), By Prostate Cancer, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Prostate Cancer, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Prostate Cancer, 2020
     4.2. Global Prostate Health Market Size (US$), By Prostate Cancer, 2018 – 2028

5. Global Prostate Health Market Size (US$), By Application I, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application I, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application I, 2020
     5.2. Global Prostate Health Market Size (US$), By Application I, 2018 – 2028

6. Global Prostate Health Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Prostate Health Market Size (US$), By End-use, 2018 – 2028

7. Global Prostate Health Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Prostate Health Market Analysis, 2018 – 2028 
          7.2.1. North America Prostate Health Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Prostate Health Market Size (US$), By Prostate Cancer, 2018 – 2028
          7.2.3. North America Prostate Health Market Size (US$), By Application I, 2018 – 2028
          7.2.4. North America Prostate Health Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Prostate Health Market Analysis, 2018 – 2028 
          7.3.1.  Europe Prostate Health Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Prostate Health Market Size (US$), By Prostate Cancer, 2018 – 2028
          7.3.3. Europe Prostate Health Market Size (US$), By Application I, 2018 – 2028
          7.3.4. Europe Prostate Health Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Prostate Health Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Prostate Health Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Prostate Health Market Size (US$), By Prostate Cancer, 2018 – 2028
          7.4.3. Asia Pacific Prostate Health Market Size (US$), By Application I, 2018 – 2028
          7.4.4. Asia Pacific Prostate Health Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Prostate Health Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Prostate Health Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Prostate Health Market Size (US$), By Prostate Cancer, 2018 – 2028
          7.5.3. Latin America Prostate Health Market Size (US$), By Application I, 2018 – 2028
          7.5.4. Latin America Prostate Health Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Prostate Health Market Analysis, 2018 – 2028 
          7.6.1.  MEA Prostate Health Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Prostate Health Market Size (US$), By Prostate Cancer, 2018 – 2028
          7.6.3. MEA Prostate Health Market Size (US$), By Application I, 2018 – 2028
          7.6.4. MEA Prostate Health Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Prostate Health Providers
        8.4.1 Eli Lilly and Company (US)
                8.4.1.1 Business Description
                8.4.1.2 Eli Lilly and Company (US) Geographic Operations
                8.4.1.3 Eli Lilly and Company (US) Financial Information
                8.4.1.4 Eli Lilly and Company (US) Product Positions/Portfolio
                8.4.1.5 Eli Lilly and Company (US) Key Developments
        8.4.2 Pfizer Inc. (US)
                8.4.2.1 Business Description
                8.4.2.2 Pfizer Inc. (US) Geographic Operations
                8.4.2.3 Pfizer Inc. (US) Financial Information
                8.4.2.4 Pfizer Inc. (US) Product Positions/Portfolio
                8.4.2.5 Pfizer Inc. (US) Key Developments
        8.4.3 Merck & Co. Inc. (US)
                8.4.3.1 Business Description
                8.4.3.2 Merck & Co. Inc. (US) Geographic Operations
                8.4.3.3 Merck & Co. Inc. (US) Financial Information
                8.4.3.4 Merck & Co. Inc. (US) Product Positions/Portfolio
                8.4.3.5 Merck & Co. Inc. (US) Key Developments
        8.4.4 GlaxoSmithKline plc. (UK)
                8.4.4.1 Business Description
                8.4.4.2 GlaxoSmithKline plc. (UK) Geographic Operations
                8.4.4.3 GlaxoSmithKline plc. (UK) Financial Information
                8.4.4.4 GlaxoSmithKline plc. (UK) Product Positions/Portfolio
                8.4.4.5 GlaxoSmithKline plc. (UK) Key Developments
        8.4.5 Abbott (US)
                8.4.5.1 Business Description
                8.4.5.2 Abbott (US) Geographic Operations
                8.4.5.3 Abbott (US) Financial Information
                8.4.5.4 Abbott (US) Product Positions/Portfolio
                8.4.5.5 Abbott (US) Key Developments
        8.4.6 Astellas Pharma Inc. (Japan)
                8.4.6.1 Business Description
                8.4.6.2 Astellas Pharma Inc. (Japan) Geographic Operations
                8.4.6.3 Astellas Pharma Inc. (Japan) Financial Information
                8.4.6.4 Astellas Pharma Inc. (Japan) Product Positions/Portfolio
                8.4.6.5 Astellas Pharma Inc. (Japan) Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Prostate Health Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Prostate Health Market Revenue, By Prostate Cancer, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Prostate Health Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Prostate Health Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Prostate Health Market Revenue, By Prostate Cancer, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Prostate Health Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Prostate Health Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Prostate Health Market Revenue, By Prostate Cancer, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Prostate Health Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Prostate Health Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Prostate Health Market Revenue, By Prostate Cancer, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Prostate Health Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Prostate Health Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Prostate Health Market Revenue, By Prostate Cancer, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Prostate Health Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Prostate Health Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Prostate Health: Market Segmentation 
FIG. 2 Global Prostate Health Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Prostate Health Market, By Prostate Cancer, 2019 (US$ Mn) 
FIG. 5 Global Prostate Health Market, By Application I, 2019 (US$ Mn) 
FIG. 6 Global Prostate Health Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Prostate Health Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Prostate Health Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Prostate Health Providers, 2019
FIG. 11 Global Prostate Health Market Revenue Contribution, By Prostate Cancer, 2019 & 2028 (Value %) 
FIG. 12 Global Prostate Health Market Revenue Contribution, By Application I, 2019 & 2028 (Value %) 
FIG. 13 Global Prostate Health Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Prostate Health Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Prostate Health Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Prostate Health Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Prostate Health Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Prostate Health Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Prostate Health market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Prostate Health Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Prostate Health Market Value, By Segment1, 2018 – 2028
TABLE  North America Prostate Health Market Value, By Segment2, 2018 – 2028
TABLE  North America Prostate Health Market Value, By Country, 2018 – 2028
TABLE  Europe Prostate Health Market Value, By Segment1, 2018 – 2028
TABLE  Europe Prostate Health Market Value, By Segment2, 2018 – 2028
TABLE  Europe Prostate Health Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Prostate Health Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Prostate Health Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Prostate Health Market Value, By Country, 2018 – 2028
TABLE  Latin America Prostate Health Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Prostate Health Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Prostate Health Market Value, By Country, 2018 – 2028
TABLE  MEA Prostate Health Market Value, By Segment1, 2018 – 2028
TABLE  MEA Prostate Health Market Value, By Segment2, 2018 – 2028
TABLE  MEA Prostate Health Market Value, By Country, 2018 – 2028
TABLE  Eli Lilly and Company (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc. (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co. Inc. (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc. (UK): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abbott (US): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Astellas Pharma Inc. (Japan): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Prostate Health Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Prostate Health Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Prostate Health Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Prostate Health Market, By Geography, 2019 (US$ Mn)
FIG.  Global Prostate Health Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Prostate Health Providers, 2016
FIG.  Global Prostate Health Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Prostate Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Benign Prostate Hyperplasia Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global 5 Alpha Reductase Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Prostatitis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Prostate Health Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Application I Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Application II Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Application III Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Prostate Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Prostate Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Prostate Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Prostate Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Prostate Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Prostate Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Prostate Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Prostate Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Prostate Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Prostate Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Prostate Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Prostate Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Prostate Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Prostate Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Prostate Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Prostate Health Market Value, 2018 – 2028, (US$ Mn)